Hepatoss
Hepatoss Products are primarily used for
Liver disease
About Hepatoss Products
Uses of Hepatoss Products
L-Ornithine L-Aspartate is used in the treatment of liver disease.
Hepatoss Products side effects
Common
Side Effect of Hepatoss is Injection site reactions (pain, swelling, redness).
How Hepatoss Products work
L-Ornithine L-Aspartate is a combination of two amino acids which works by protecting the liver from harmful chemical substances (free radicals), thus preventing liver damage.
Patient Concerns about Hepatoss Products
Frequently asked questions about Hepatoss Products
Frequently asked questions about L-Ornithine L-Aspartate
Q. Is it ok to take alcohol when taking Hepatoss 5gm Infusion?
No, it is not recommended to take alcohol when on Hepatoss 5gm Infusion. It is a medicine given in cases of liver failure. Although, there are no reported interaction. Still, in cases of liver failure, alcohol should be avoided as it could worsen your complication of liver disease.
Q. What is Hepatoss 5gm Infusion?
Hepatoss 5gm Infusion is made up of two amino acids. It is most commonly used in cases of liver diseases in order to prevent it from abnormal brain function called hepatic encephalopathy.
Q. What is the use of Hepatoss 5gm Infusion in the treatment of hepatic encephalopathy (HE)?
Hepatic encephalopathy (HE) is a brain disorder which occurs in patients with liver failure. In liver failure, there is increased bacterial growth in the intestine which leads to an accumulation of ammonia in blood. This deteriorating condition of the liver starts affecting the functioning of the brain, causing Hepatic encephalopathy. Hepatoss 5gm Infusion works by detoxifying the ammonia from the blood, hence decreasing the free ammonia from the body. This, as a result, helps decrease the abnormal functioning of the brain caused due to liver failure.
Q. How is Hepatoss 5gm Infusion given?
Hepatoss 5gm Infusion can be given daily as an injection that is injected into the veins. Your doctor will suggest the appropriate dose depending on the patient’s health condition and severity of the disease.